May 09, 2023 / 12:15PM GMT
Peter Hugreffe Ankersen - Novo Nordisk A/S-Head of IR&Corporate VP
Actually, it's Pete Verdult from Citi. So welcome, everyone. On behalf of Citi, delighted to have Karsten Knudsen, Group CFO; and Martin Lange, Head of R&D; plus various members of the Novo [Nordisk] team in London for the Q1 roadshow. You all know the drill, short presentation and then straight into Q&A. A bit of housekeeping. There are microphones on each of the tables, which are on currently. So if you can all have your phones on silent and try and eat quietly and cluster less, that'll be fantastic.
So without further ado, Karsten Knudsen. Thank you.
Karsten Munk Knudsen - Novo Nordisk A/S-Executive VP - CFO & Member of the Management Board
Thanks, Pete, and thanks for the invitation and you're hosting our Novo Nordisk Q1 roadshow in the London lunch meeting in conjunction with Q1. We're bringing fantastic set of numbers. So it's great to be in London and see you all and also
Q1 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
May 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers